ArticleInternational journal of medical sciences2021

The combination therapy with EpCAM/CD3 BsAb and MUC-1/CD3 BsAb elicited antitumor immunity by T-cell adoptive immunotherapy in lung cancer.

Ce Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.